memoria 2015

204 Pages·2016·3.98 MB·English

Contents
1. Director’s Foreword ................................................... pg 4
2. Human, Technological and Economic Resources ....... pg 9
3. Goals achieved in 2015 ............................................ pg 17
4. External Scientifi c Advisory Board ............................. pg 21
5. Participation in Networks .......................................... pg 25
6. Training Activities ..................................................... pg 29
7. Infrastructures .......................................................... pg 41
8. Biomedical Research Support Units .......................... pg 45
9. Scientifi c Production ................................................ pg 57
10. Scientifi c Production at a glance ........................... pg 187
11. Knowledge Transfer .............................................. pg 195
12. Goals for 2016 ...................................................... pg 199

1
Director’s
Foreword
1.
Director’s
Foreword
The Maimonides Institute for Biomedical Research of
Córdoba (IMIBIC) crystallizes the integrated eff orts of
individuals and institutions united around the common goal
of improving the health of patients and the community,
through excellence in science and innovation in biomedical
research. The compromise of IMIBIC with quality, talent,
and cooperation as keys for translational science
continues growing since the inception of the Institute, in
2008, through the integrated agreement and generous
contribution of several institutions. In 2011, IMIBIC was
endorsed by the Health Institute Carlos III as an accredited
Health Research Institute, and the ensuing fi ve years have
witnessed a steady progression of IMIBIC in the quest to
develop an independent research center of excellence
with a translational nature and a vocation to improve the
quality of life of patients. The growth and maturation of
IMIBIC and its achievements in this intense period are those
of the human team that embodies the Institute: over 500
clinicians, nurses, basic and translational researchers, and
The Maimonides Institute personnel in technical, management, and administrative
areas; an enthusiastic and hardworking crew joined in the
for Biomedical Research of
quest for this common praiseworthy ambition of improving
Córdoba (IMIBIC) crystallizes patient’s health through biomedical research.
the integrated efforts of The year 2015 represented a signifi cant landmark
for IMIBIC. The transition to a novel team in the Scientifi c
individuals and institutions
Direction of the Institute was accompanied by the crucial
united around the common move to the new facilities, our fl agship building for basic
and translational research. The new building is located
goal of improving the health of
within the University Health Sciences Campus by the Reina
patients and the community,
Sofía University Hospital. With 10.000 sq, it provides new
through excellence in science facilities for researchers, who have at their disposal 5.500
sq for laboratory space plus 900 sq for the new Experimental
and innovation in biomedical
Animal Service facilities. The building gathers the core of
research. research teams of IMIBIC, in a place where they have at
hand everything they need to develop their research.
4 IMIBIC SCIENTIFIC REPORT 2015
Along the same lines, we are especially proud of impact factor was 1303.75 points. The improvement in
the establishment of the Clinical Research Unit, with the quality of our work is commendable, for 26,5% of our
two main facilities occupying 2.000 sq. This year 2015 publications are found within the fi rst decile journals and
has seen the inauguration of these two new facilities for 52,1% in fi rst quartile journals.
Clinical Research, located in the Hospital Provincial and the Moreover, the Institute has made great advances in one
General Hospital’s Clinical Research Building, respectively. of our main objectives: promoting biomedica l innovation as
More than 300 patients have been already treated at these a powerful engine for economic and social development. In
facilities. This enables a signifi cant improvement in the 2015, 21 property registries were fostered at the heart of
quality of care provided in clinical trials. There has been the Institute. These facts clearly show that there has been
a 150% increase in independently led new clinical trials, more growth compared to the previous year.
and a 233% increase in the number of new observational IMIBIC has continued to implement new strategies
studies. to increase fundraising through EU and international
programmes. A total of 5 projects are active in 2015,
including one clinical trial funded by the 7FP, one
The year 2015 represented a
research project from the Innovative Medicines Initiative,
signifi cant landmark for IMIBIC. The
two coordination activities on Pre-commercial Public
transition to a novel team in the Procurement of Innovation, and one Marie S. Curie Action.
A further three proposals submitted in 2014 and 2015
Scientifi c Direction of the Institute was
have been funded, one Pre-commercial Procurement of
accompanied by the crucial move to Innovation Action, one clinical trial on paediatric oncology
and one research project on e-health and diabetes. The
the new facilities, our fl agship building
aim is maintain a level of success that allows a steady
for basic and translational research,
increment of funds from international programmes. 
and the Clinical Research Unit. The present Scientifi c Report depicts and summarizes
the daily life of IMIBIC in 2015, and will hopefully serve as a
portrait and ambassador of our research activity. The human
As per above, the research output of the institute has team that comprises the Institute, with the unrestrained
grown signifi cantly in quantity and quality over the last support of our institutions, will enthusiastically continue
years. Indeed, despite the complex general situation for the collaborative research work that should lead us to
research funding nationwide, the intense research activity achieve our mission. 
compiled and summarized in this report illustrates excellent
indicators of generation and transfer of knowledge. In
2015, IMIBIC managed to continue increasing its scientifi c Justo P. Castaño
output, with 359 papers, of which 33% were published in Scientifi c Director
collaboration with foreign groups and institutions. The total
IMIBIC SCIENTIFIC REPORT 2015 5

2
Human, Technological
and Economic
Resources